Fasenra: Clinical Trials

3 trials of Fasenra, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 enrolling by invitation, 1 recruiting. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 1, Enrolling by invitation 1, Recruiting 1

Follow Fasenra: new trials by email Literature Review of Fasenra trials Research Report on Fasenra

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fasenra: An Asthma Study
Budesonide-albuterol, Benralizumab - Eosinophilic Asthma, Severe Asthma
Phase 4Enrolling by invitationEndeavor Health402026-07-012026-09-15
Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
Dupilumab, Benralizumab - Moderate to Severe Asthma
Phase 4RecruitingUniversity of California, San Diego1202024-02-192024-08-19
BURAN: Benralizumab on Airway Dynamics in Severe Eosinophilic Asthma Using Functional Respiratory Imaging
Benralizumab - Asthma
Phase 4CompletedAstraZeneca452022-10-112025-03-25

Conditions studied

Asthma (3)  ·  Pulmonary Eosinophilia (2)

Sponsors

AstraZeneca (1)  ·  Endeavor Health (1)  ·  University of California, San Diego (1)

Countries

United States (3)  ·  Australia (1)  ·  Belgium (1)  ·  France (1)  ·  Portugal (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Giselle Mosnaim, MD, MS (1)  ·  Kelan Tantisira, MD (1)

Results publications

PMID 37131265, PMID 42458446

NIH funding

R01HL161362 (1)